Diagnostic Hybrids Overview

  • Founded
  • 1982
  • Status
  • Acquired/​Merged
  • Employees
  • 220
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $131M
Latest Deal Amount

Diagnostic Hybrids General Information


Developer of diagnostic cell cultures and virus detection kit systems used in the clinical diagnosis of infectious and autoimmune diseases. The company offers D3 FastPoint L-DFA influenza A/influenza B virus identification kit, which allows for the identification of influenza A virus and influenza B virus from a patient's specimen. It also develops and commercializes genetically engineered cell-based detection products for the pharmaceutical and biotechnology industry with a focus on pharmacology assays and products that measure drug clearance and anti-viral interventions with drugs and vaccines.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 350 West State Street
  • Athens, OH 45701
  • United States
+1 (740) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Diagnostic Hybrids Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 19-Feb-2010 $131M 0000 00000 Completed Generating Revenue
1. Later Stage VC 11-Aug-2004 0000 0000 Completed Generating Revenue
To view Diagnostic Hybrids’s complete valuation and funding history, request access »

Diagnostic Hybrids Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Diagnostic Hybrids Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kenson Ventures Venture Capital Minority 000 0000 000000 0
Summit Partners PE/Buyout Minority 000 0000 000000 0
To view Diagnostic Hybrids’s complete investors history, request access »